---
category: news
title: "Massive Bio Has Been Awarded a Contract by the NCI to Develop an Oncology Based Artificial Intelligence-Enabled Clinical Trial Recruitment Tool"
excerpt: "Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment, announced today it has been awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI) to develop and characterize the Deep Learning Clinical Trial Matching System (DLCTMS)."
publishedDateTime: 2020-12-17T13:01:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-business-new-york-corporate-news-drug-trials-ecf7d1982f86400989fc9279517facd7"
webUrl: "https://apnews.com/press-release/business-wire/technology-business-new-york-corporate-news-drug-trials-ecf7d1982f86400989fc9279517facd7"
type: article
quality: 3
heat: 3
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "+F5bRUPLP41vcx0SS62ZYRGevS7eG8a8/eBMjOweqj/QrQYY7BHbrRNV1MHk22OqHlLa4FjmmuLeJ4XckBoo4SM1TxSyFOUETMj8d0xnyb358LY86AvMJ351XJ9ztzn10q2MJCvRDvl6kKNXtySgKHGPQfTeH8QN+1DqMtwA2Lsnup94NKfXxlZtrVHmMtWQa3zDTBmjWTWjDGH90x1QTO3yMhjY64MmLZ/mTwYMjQhBJ6shSXhzhA8cn6JGKrptPYlS8dpyBe+BB7rx7ll7eMhS6LASwuW56H80967lx/5jTtzx5JL4v8ewIswHlVNGP6wmnktHOuy9OEgPLwz6qUelT91CmbIQ5SzikQLZqXI=;X+zn587Y460ovPWOuMKpQg=="
---

